Johnson & Johnson Coronavirus vaccine illustration
Dado Ruvic | Reuters
Jeff Zients said the administration has learned in the last couple of weeks that J&J will have only “a few million” doses manufactured when its single-shot vaccine is likely authorized by the Food and Drug Administration.
Federal and state health officials were expecting vaccine supply to rapidly increase after the emergency use authorization of J&J’s vaccine. The FDA has scheduled a meeting of its Vaccines and Related Biological Products…